KAIST Develops Light-Activated 'Smart Antibody' to Control Cancer Cell Attacks
KAIST Professor Heo Won-do's team has developed "ExtraBody," a light- and chemical-activated antibody platform that precisely controls when and where immune cells attack cancer cells.
Why this byte is shareable
Signal quality
observed
Confidence badge and source context included.
Entity anchor
AI News
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
AI News is moving the AI stack right now, and this update helps explain what changed for builders.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
KAIST Develops Light-Activated 'Smart Antibody' to Control Cancer Cell Attacks Why it matters: AI News is moving the AI stack right now, and this update helps explain what changed for builders. Source: 서울경제 https://a2zai.ai/bytes/kaist-develops-light-activated-smart-antibody...
Permalink: https://a2zai.ai/bytes/kaist-develops-light-activated-smart-antibody-to-control-cancer-cell-attacks-beb9d34f
Social card: https://a2zai.ai/bytes/kaist-develops-light-activated-smart-antibody-to-control-cancer-cell-attacks-beb9d34f/opengraph-image